Selexipag: A New Treatment Agent for Pulmonary Arterial Hypertension
Journal Title: Meandros Medical and Dental Journal - Year 2019, Vol 20, Issue 1
Abstract
Pulmonary arterial hypertension (PAH) is a rare disease which is characterized by the progressive increase of pulmonary arterial pressure. PAH can lead to right cardiac insufficiency and death. Conventional and other treatment modalities that target the physiopathological and etiopathological causes of the disease are currently being used. Selexipag is an oral selective prostacyclin receptor agonist which was developed to overcome the pathophysiological mechanisms that play role in the PAH.
Authors and Affiliations
Onur Yazıcı, Hasan Güngör
Non-surgical Root Canal Retreatment: A Retrospective Outcome Study
Objective: When the prognosis of a root canal treated (RCT) teeth is poor, retreatment (RT) of the former RCT is indicated. The aim of this study was to assess the long-term success rate of nonsurgical retreatment for fi...
Effect of Poly(Methyl Vinyl Ether-comaleic Anhydride) Copolymer on Bond Strength of Experimental Dental Adhesive
Objective: The contents of adhesive systems directly affect their bond strength. The purpose of this in vitro study was to evaluate the bond strength of experimental two-step self-etch (SE) adhesive containing Poly(methy...
The Influence of Iron Supplementation on Tooth Eruption of the Newborn
Objective: Iron is needed for many enzymes to function normally, so a wide range of symptoms may eventually emerge in iron deficiency, including retardations in growth and maturation. Because of this it is reasonable to...
Ultrasonographically Diagnosed Bicipital Fasciitis: The Importance of Ultrasonography for Early Diagnosis and Emphasis on Aseptic Technique
Here, we present a case of bicipital fasciitis after intraarticular injection of the shoulder joint. Bicipital fasciitis was diagnosed using real-time ultrasonography. The infection was probably due to non-compliance wit...
The Relationship Between Monocyte Count to High-density Lipoprotein Ratio and Severity of Inflammation in Aggressive Periodontitis: A Retrospective Analysis
Objective: Hyperlipidemia is a known cardiovascular disease risk factor. A common biological mechanism between systemic diseases, such as cardiovascular diseases, and periodontal diseases has been suggested. This study a...